New findings in preventing recurrence and improving renal function in AHUS patients after renal transplantation treated with eculizumab: a systemic review and meta-analyses
Background The long-term mortality of kidney transplantation patients with atypical hemolytic uremic syndrome remains high, and the efficacy of the main treatment eculizumab is still controversial.Objective A comprehensive systematic review and meta-analysis of clinical trials using eculizumab in re...
Saved in:
| Main Authors: | Zheng Chun Tang, Huang Hui, Chunru Shi, Xiangmei Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Renal Failure |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2023.2231264 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Global aHUS Registry Analysis of Patients Switching to Ravulizumab From Eculizumab
by: Franz Schaefer, et al.
Published: (2024-09-01) -
Clinical case of recurrent aHUS after allogeneic cadaveric kidney transplantation
by: S. V. Popov, et al.
Published: (2024-01-01) -
Scleroderma Renal Crisis Debute with Thrombotic Microangiopathy: A Successful Case Treated with Eculizumab
by: Maite Hurtado Uriarte, et al.
Published: (2018-01-01) -
Transplant-associated Thrombotic Microangiopathy: An Enigma Treated with Eculizumab
by: S. Ravitej, et al.
Published: (2024-10-01) -
WCN24-640 ECULIZUMAB SPARING PROTOCOLS IN RENAL TRANSPLANTATION OF CASES OF ATYPICAL HEMOLYTIC UREMIC SYNDROME: A ONE YEAR FOLLOW UP STUDY
by: Kartik Ganesh, et al.
Published: (2024-04-01)